Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Deyan Davidov"'
Autor:
Deyan Davidov
Publikováno v:
Journal of IMAB, Vol 23, Iss 2, Pp 1532-1535 (2017)
Objective: The aim of this study was to investigate the prognostic significance for survival of certain clinical and pathological factors in patients with advanced or metastatic colorectal carcinoma (CRC) treated with first- line chemotherapy. Method
Externí odkaz:
https://doaj.org/article/470521140e004c23a2bfdcb9d8f42943
Autor:
Deyan Davidov
Publikováno v:
Journal of IMAB, Vol 22, Iss 1, Pp 1045-1049 (2016)
Objective: The aim of this study was to investigate the prognostic significance for survival of certain clinical and pathological factors in patients with advanced or metastatic renal cell carcinoma (mRCC) treated with chemotherapy. Methods: From 199
Externí odkaz:
https://doaj.org/article/5194d83a03ab438da8bbaad55fde3e75
Autor:
Deyan Davidov
Publikováno v:
Journal of IMAB, Vol 22, Iss 1, Pp 1036-1038 (2016)
Objective: The standard treatment for inoperable skin melanoma is chemotherapy. The aim of this study was to explore the efficacy and safety of therapy with dacarbazine in patients with advanced melanoma. Methods: Twenty- seven consecutive patients w
Externí odkaz:
https://doaj.org/article/aac2bc18f74640019c19a91c47cd5436
Autor:
Deyan Davidov
Publikováno v:
Journal of IMAB, Vol 20, Iss 6, Pp 556-559 (2014)
Objective: Bevacizumab improved survival when added to chemotherapy for patients with metastatic colorectal cancer (mCRC). The aim of this study was to explore the efficacy and safety of Bevacizumab containing chemotherapy regimen in the treatment of
Externí odkaz:
https://doaj.org/article/6dd92a71edfe49e58a282bc9b9bc611c
Autor:
Deyan Davidov
Publikováno v:
Journal of IMAB, Vol 20, Iss 6, Pp 560-564 (2014)
Objective: The aim of this study was to evaluate elevated platelet count as a prognostic factor for survival in patients with advanced (stage IIIB/ IV) non- small cell lung cancer (NSCLC) receiving first- line chemotherapy. Methods: From 2005 to 2009
Externí odkaz:
https://doaj.org/article/042c4807c77648bbb4ce1204ea1a1d08
Autor:
Deyan Davidov
Publikováno v:
Journal of IMAB, Vol 16, Iss 3, Pp 74-77 (2010)
Objectives: Capecitabine is an oral fluoropyrimidine carbamate that is at least as effective than Fluorouracil / Leucovorin as first- line treatment for patients with metastatic colorectal cancer /CRC/. The topoisomerase I inhibitor Irinotecan has sh
Externí odkaz:
https://doaj.org/article/7a3fef5ebae040ed90d3d7444b1bdbf9
Autor:
Deyan Davidov
Publikováno v:
Journal of IMAB, Vol 16, Iss 3, Pp 70-73 (2010)
Objectives: Single agent intravenous Topotecan is an effective treatment for small cell lung cancer /SCLC/ after failure of first- line chemotherapy. The aim of this study was to evaluate the efficacy and toxicity of intravenous Topotecan in recurren
Externí odkaz:
https://doaj.org/article/92e49ad2bcb04b88bffea317d692c2d0
Autor:
Deyan Davidov
Publikováno v:
Journal of IMAB, Vol 14, Iss 1, Pp 51-54 (2008)
Background: A platinum- based doublets with a third- generation agents /Gemcitabine, Vinorelbine/ represent the standard first- line treatment for advanced patients with non- small- cell lung cancer /NSCLC/ and good performance status. Aim: The aim o
Externí odkaz:
https://doaj.org/article/10890d2fabc64cdeb76194509d5ece17
Autor:
Deyan Davidov
Publikováno v:
Journal of IMAB, Vol 14, Iss 1, Pp 48-50 (2008)
Background: Irinotecan is a topoisomerase I inhibitor that prolongs survival as second- line therapy in patients with metastatic colorectal cancer, treated with Fluorouracil and Leucovorin only. Aim: The aim of this study was to evaluate the efficacy
Externí odkaz:
https://doaj.org/article/730245020ac34f628c72c0f7ae0079e4
Autor:
Deyan Davidov
Publikováno v:
Journal of IMAB, Vol 16, Iss 3, Pp 70-73 (2010)
RESUME: Objectives: Single agent intravenous Topotecan is an effective treatment for small cell lung cancer /SCLC/ after failure of first- line chemotherapy. The aim of this study was to evaluate the efficacy and toxicity of intravenous Topotecan in